文献速递神经MR

胶质瘤术后肿瘤复发与假性进展的鉴别:六种扩散模型对比研究

Differentiation of Postoperative Tumor Recurrence and Pseudoprogression in Gliomas: A Comparative Study of Six Diffusion Models.
PubMed 文献 · Acad Radiol · 2025-08-07

该回顾性研究纳入82例WHO 2-4级胶质瘤术后患者,基于多b值DWI拟合六种扩散模型鉴别肿瘤复发(46例)与假性进展(36例)。除IVIM_D*和IVIM_f外各模型参数均有显著差异,CTRW_D的AUC最高为0.8484,CTRW模型整体AUC为0.8635,略高于FROC模型的0.8629。

要点

  • 多b值DWI衍生的六种扩散模型可有效鉴别胶质瘤术后复发与假性进展。
  • CTRW_D的AUC最高,为0.8484(0.7549-0.9240)。
  • CTRW与FROC模型诊断性能最佳且相近,AUC分别为0.8635与0.8629。

核心结论

  • 多b值DWI序列衍生的各种扩散模型能有效区分胶质瘤术后复发与假性进展,其中CTRW和FROC为两种最优模型,诊断性能相当。

研究设计与样本

  • 回顾性研究,纳入82例在本院接受手术的WHO 2-4级胶质瘤患者,MRI序列包括T1WI、T2WI、T2FLAIR、增强T1WI和多b值DWI;术后随访或二次手术病理确诊复发46例、假性进展36例;基于多b值DWI拟合六种扩散模型:单指数DWI、体素内不相干运动、扩散峰度成像、拉伸指数模型、分数阶微积分和连续时间随机游走模型;手动勾画ROI计算各参数平均值。

诊断标准与关键数值

  • 14个参数图中除IVIM_D*和IVIM_f外各模型参数在两组间均有显著差异(P<0.0036);ROC分析示CTRW_D的AUC最高为0.8484(0.7549-0.9240);模型层面CTRW的AUC为0.8635(0.7816-0.9454),略高于FROC模型的0.8629(0.7839-0.9420)。

临床应用与阅片要点

  • 作者认为多b值DWI衍生的扩散模型可有效鉴别胶质瘤术后复发与假性进展。
  • 作者认为CTRW和FROC为两种最优模型,诊断性能相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: The purpose of this study is to investigate whether six diffusion models derived from multi-b-value diffusion-weighted imaging can enhance the differentiation between pseudoprogression (PsP) and postoperative tumor recurrence (TR) in glioma patients, with the aim of providing clinical insights.

MATERIALS AND METHODS: A retrospective study was conducted on 82 patients with WHO grade 2-4 gliomas who underwent surgery at our hospital, with MRI sequences including T1WI, T2WI, T2FLAIR, contrast-enhanced T1WI, and multi-b-value DWI. Postoperative follow-up or secondary surgery pathology confirmed 46 cases of TR and 36 cases of PsP. Six diffusion models were fitted based on multi-b-value DWI sequences, including monoexponential DWI (Mono_DWI), intravoxel incoherent motion (IVIM), diffusion kurtosis imaging (DKI), stretched-exponential model (SEM), fractional-order calculus (FROC), and continuous-time random-walk (CTRW) model. ROIs were manually outlined to calculate the average values of each parameter. Differences between the two groups were compared using T-tests or Mann-Whitney U tests. The diagnostic performance of individual parameters was analyzed using ROC curve analysis, and the diagnostic performance of each model was compared using multivariate logistic regression.

RESULTS: Among the 14 parameter maps, significant differences were found in all models (P<0.0036) except for IVIM_D*, IVIM_f. ROC curve analysis showed that CTRW_D demonstrated the highest AUC of 0.8484 (0.7549-0.9240). Further analysis of the diffusion models showed that CTRW performed the best among all models, with an AUC of 0.8635 (0.7816-0.9454), slightly higher than the FROC model, which had an AUC of 0.8629 (0.7839-0.9420).

CONCLUSION: The various diffusion models derived from multi-b-value DWI sequences can effectively distinguish between postoperative recurrence and pseudoprogression in gliomas. Among these models, the CTRW and FROC models are the two optimal models, demonstrating comparable diagnostic performance.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Liu P, Chen Y, Zhao J, et al. Differentiation of Postoperative Tumor Recurrence and Pseudoprogression in Gliomas: A Comparative Study of Six Diffusion Models. Acad Radiol. 2025. PMID: 40774877. doi:10.1016/j.acra.2025.07.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。